Zhejiang Huakang Pharmaceutical Co Ltd (605077) — Capital Reinvestment Ratio
Zhejiang Huakang Pharmaceutical Co Ltd (605077) has a Capital Reinvestment Ratio of 9.76x as of December 2024, meaning it reinvests 10% of its operating cash flow (CN¥146.50 Million) in capital expenditures (CN¥1.43 Billion). See 605077 cash flow after capex ratio to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Zhejiang Huakang Pharmaceutical Co Ltd Capital Reinvestment Ratio (2016–2024)
This chart tracks Zhejiang Huakang Pharmaceutical Co Ltd's Capital Reinvestment Ratio across 9 annual periods.
Annual Capital Reinvestment Ratio for Zhejiang Huakang Pharmaceutical Co Ltd (2016–2024)
Year-by-year Capital Reinvestment Ratio for Zhejiang Huakang Pharmaceutical Co Ltd from 2016 to 2024. For live market cap and broader valuation context, see 605077 stock market capitalisation.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 9.76x | CN¥146.50 Million | CN¥1.43 Billion | ▲ +775.3% |
| 2023 | 1.11x | CN¥619.47 Million | CN¥690.70 Million | ▼ -43.8% |
| 2022 | 1.98x | CN¥271.98 Million | CN¥539.75 Million | ▲ +45.3% |
| 2021 | 1.37x | CN¥264.32 Million | CN¥360.93 Million | ▲ +81.0% |
| 2020 | 0.75x | CN¥335.24 Million | CN¥252.95 Million | ▲ +60.5% |
| 2019 | 0.47x | CN¥281.31 Million | CN¥132.21 Million | ▼ -45.4% |
| 2018 | 0.86x | CN¥140.97 Million | CN¥121.38 Million | ▲ +320.6% |
| 2017 | 0.20x | CN¥80.56 Million | CN¥16.49 Million | ▼ -24.8% |
| 2016 | 0.27x | CN¥93.02 Million | CN¥25.32 Million | — |